Salsbury Michael 4

What Happened Michael Salsbury, a director of MetaVia, was granted 17,186 restricted stock units (RSUs) on June 8, 2026. The grant has a $0.00 acquisition price (i.e., no cash paid) and therefore no immediate purchase value. This is an award/grant (not a sale or open-market purchase); the RSUs will convert to shares only upon vesting per the plan terms.

Key Details

• Transaction date and price: 2026-06-08; 17,186 RSUs granted at $0.00.
• Vesting: RSUs vest on the earlier of June 8, 2027 or the day before MetaVia’s 2027 annual meeting, subject to Salsbury’s continued service.
• Deferral: Per the Issuer’s Non-Employee Director Compensation Policy, Salsbury elected to defer receipt of the underlying shares until the earlier of (i) immediately prior to a Change in Control or (ii) within 60 days after retirement/separation or death.
• Shares owned after transaction: Not specified in this Form 4; the filing notes total beneficial ownership was adjusted for a 1-for-11 reverse split completed on December 4, 2025.
• Filing timeliness: Report filed on 2026-06-08 (same date as the transaction), indicating a timely Form 4 filing.

Context RSUs are a grant of future shares that vest over time and are not an immediate purchase or sale; because Salsbury has deferred receipt of the shares, he will not receive the underlying common stock at vesting unless and until a deferral trigger occurs as described. Awards like this are routine director compensation and should be interpreted as an issuance of long-term equity rather than an immediate market action.